C09DX01 |
B |
Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg |
11781 |
138023/1 |
EXFORGE HCT |
|
28 |
Tablet, film coated |
Oral |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA |
Italy |
1,333,092 L.L |
23.08 |
A2 |
Novartis Pharma AG |
Switzerland |
04/03/20 |
|
C09DX01 |
G |
Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg |
11257 |
6120/1 |
LOTEVAN PLUS |
|
30 |
Tablet, film coated |
Oral |
Mersaco |
Tabuk Pharmaceutical Manufacturing Company |
Saudi Arabia |
857,372 L.L |
23.08 |
A2 |
Tabuk Pharmaceutical Manufacturing Company |
Saudi Arabia |
04/03/20 |
|
C09DX01 |
G |
Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg |
11336 |
10122/1 |
VIOSTAN AM PLUS 160/5/12.5 |
|
30 |
Tablet, film coated |
Oral |
Benta Trading Co s.a.l. |
Benta SAL |
Lebanon |
1,196,020 L.L |
23.08 |
B |
|
|
04/03/20 |
|